Comparative evaluation of serum TGF-β1 and PDGF-BB levels across patients with normal coronary arteries, stable coronary artery disease, and acute coronary syndrome
Open Access
- 27 July 2026
- journal article
- research article
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 26 (1)
Abstract
To compare serum levels of Transforming Growth Factor-Beta (TGF-β) and Platelet-Derived Growth Factor-BB (PDGF-BB) among patients with normal coronaryKeywords
This publication has 28 references indexed in Scilit:
- Prognostic value of residual SYNTAX score in patients with coronary artery disease undergoing percutaneous coronary intervention-cohort studyIndian Heart Journal, 2024
- 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary DiseaseJACC, 2023
- Fundamental Pathobiology of Coronary Atherosclerosis and Clinical Implications for Chronic Ischemic Heart Disease Management—The Plaque HypothesisJAMA Cardiology, 2023
- Stable CAD patients show higher levels of platelet-borne TGF-β1 associated with a superior pro-inflammatory state than the pro-aggregatory status; Evidence highlighting the importance of platelet-derived TGF-β1 in atherosclerosisJournal of Thrombosis and Thrombolysis, 2022
- Plaque erosion and acute coronary syndromes: phenotype, molecular characteristics and future directionsNature Reviews Cardiology, 2021
- Diagnosis and Management of Stable AnginaJAMA, 2021
- Lower levels of high-density lipoprotein cholesterol are associated with increased cardiovascular events in patients with acute coronary syndromeAtherosclerosis, 2020
- Coronary Artery Disease: From Mechanism to Clinical Practice2020
- Simvastatin reduces TGF-β1-induced SMAD2/3-dependent human ventricular fibroblasts differentiation: Role of protein phosphatase activationInternational Journal of Cardiology, 2018
- Platelet-derived growth factor. II. Specific binding to cultured cells.Journal of Biological Chemistry, 1982